Health Trials

Relapsed/Refractory Plasma Cell Leukemia

2

Review clinical trials related to Relapsed/Refractory Plasma Cell Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia

A Clinical Study to Explore the Safety, Efficacy, and Cellular Metabolic Dynamics of CT0596 CAR-T Cell Injection in Patients With Relapsed/Refractory Multiple Myeloma and Plasma Cell Leukemia.

Participants needed: 24
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Soochow UniversityUpdated: Oct 1, 2025Locations: 1
Eligibility criteria

Patients must voluntarily sign the informed consent form (ICF) and must be willi... [+7]

1. Pregnant or lactating women; 2. Patient has any significant condition(s), lab...

Read more
Status: Recruiting

a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia

This study is a single-arm, open-label, exploratory dose-escalation and dose-finding clinical trial to evaluate the safety, efficacy, cellular pharmacokinetics and pharmacodynamics of CT0596 cells in patients with R/R MM and PCL.RRMM and RRpPCL

Participants needed: 24
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Changzheng HospitalUpdated: Dec 12, 2024Locations: 1
Eligibility criteria

Patients must voluntarily sign the informed consent form (ICF) and must be willi... [+7]

Pregnant or lactating women; [+16]

Read more